Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04669548 · ClinicalTrials.gov registry record
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
A clinical trial of Acute Kidney Injury and Intraabdominal Hypertension, sponsored by Potrero Medical.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 9
- Study locations
NCT04669548 is a study of Acute Kidney Injury and Intraabdominal Hypertension that is actively recruiting participants, run by Potrero Medical. The registered enrollment target is 2,500 participants, roughly in line with the 2,297-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target. The trial reports 9 study locations across 6 states.
The verdict
NCT04669548, a study of Acute Kidney Injury and Intraabdominal Hypertension, is actively recruiting participants, sponsored by Potrero Medical.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 9
- Study locations
Study Summary
The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.
Conditions Studied
Interventions
- DEVICE Accuryn Monitoring System
Study Locations (9)
North Carolina
- Mission Health Hospital - Asheville
- Duke University Hospital - Durham
- Wake Forest Baptist Medical Center - Winston-Salem
California
- Cedars-Sinai Medical Center - Los Angeles
- San Francisco VA Medical Center - San Francisco
District of Columbia
- George Washington University Hospital - Washington D.C.
Florida
- Cleveland Clinic Florida - Weston
Kentucky
- Jewish Hospital / University of Louisville - Louisville
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04669548
The ClinicalTrials.gov registry entry for NCT04669548 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,297-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target. The listed sponsor is Potrero Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 1 intervention - of which Accuryn Monitoring System is the first listed.
NCT04669548 reports 9 study locations spanning 6 distinct geographic areas - top geographies include North Carolina, California, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04669548 about?
NCT04669548 is a clinical study titled "Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry". The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using elect...
What is the current status of trial NCT04669548?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2020-12-21. Estimated completion is 2026-12-31.
What conditions does trial NCT04669548 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Intraabdominal Hypertension, Abdominal Compartment Syndrome, Cardiovascular Surgery.
What interventions are being tested in trial NCT04669548?
The interventions under investigation include: Accuryn Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT04669548?
This trial is sponsored by Potrero Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04669548 being conducted?
This trial has 9 study locations across California, District of Columbia, Florida, Kentucky, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
-
Melatonin for Prevention of Kidney Injury
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.